GLP-1s, Type 1 Diabetes & Menopause: Do You Really Need One?
GLP-1 medications are everywhere right now.
And if you're a woman with type 1 diabetes navigating perimenopause or menopause, you may be wondering whether a GLP-1 could help with weight gain, increasing insulin resistance, higher insulin needs, or blood sugars that suddenly feel harder to manage.
It's a fair question.
But before asking, “Do I need a GLP-1?” I think we need to ask something even more important:
What am I actually trying to solve?
Many of the changes that make GLP-1 medications appealing, including weight gain, changing body composition, increased appetite, sleep disruption, and worsening insulin sensitivity, can also show up as our hormones change during perimenopause and menopause.
That doesn't mean a GLP-1 isn't appropriate. And it doesn't mean hormone therapy is automatically the answer.
It means women with type 1 diabetes deserve a bigger conversation. We need to look at GLP-1 medications, insulin, hormones, muscle, nutrition, sleep, stress, and metabolic health together.
So, let's break down what GLP-1 medications actually do, what the research says about GLP-1 use in type 1 diabetes, what women in menopause should consider, and the questions worth asking before deciding whether one belongs in your toolbox.
What Are GLP-1 Medications and How Do They Work?
GLP-1 stands for glucagon-like peptide-1, a hormone produced primarily in the gut. It plays a role in appetite, fullness, digestion, and blood sugar regulation.
GLP-1 receptor agonist medications mimic some of these effects. They can increase feelings of fullness, slow gastric emptying, and influence glucose regulation and appetite.
There's an interesting connection for those of us with type 1 diabetes. When pancreatic beta cells are destroyed, we lose not only insulin production but also the hormone amylin. Amylin normally helps regulate glucagon, fullness, and gastric emptying, some of the same areas influenced by GLP-1 medications.
But here's an important distinction:
GLP-1 medications are not insulin and do not replace insulin in type 1 diabetes.
They are not currently FDA-approved specifically for the treatment of type 1 diabetes. However, the American Diabetes Association's 2026 Standards of Care recommend considering GLP-1 receptor agonist-based therapy for obesity management in adults with type 1 diabetes and obesity, with individualized care and shared decision-making.
GLP-1 Medications: Ozempic, Wegovy, Mounjaro, Zepbound and More
The generic names, brand names, and approved uses can get confusing.
Here's a simplified breakdown:
Semaglutide
Ozempic: weekly injection
Wegovy: weekly injection
Rybelsus: oral semaglutide
Tirzepatide
Mounjaro: weekly injection
Zepbound: weekly injection
Tirzepatide acts on both GIP and GLP-1 receptors.
Liraglutide
Victoza: daily injection
Saxenda: daily injection
Dulaglutide
Trulicity: weekly injection
Exenatide
Byetta: twice-daily injection
Bydureon BCise: weekly injection
For another helpful overview, the National Institute of Diabetes and Digestive and Kidney Diseases explains prescription weight-management medications, including how they're used and factors to consider when choosing one.
These medications don't all have the same FDA-approved indications. That's why it's important to discuss the specific medication and the reason you're considering it, rather than simply asking for “a GLP-1.”
GLP-1 and Type 1 Diabetes: What Does the Research Show?
Weight loss gets much of the attention, but that's not the entire story for women with type 1 diabetes.
Recent research examining GLP-1 receptor agonists used alongside insulin in type 1 diabetes has found modest improvements in A1C and time-in-range, along with reductions in insulin requirements and body weight.
That's encouraging, but it doesn't mean every person with T1D needs one.
Using these medications with type 1 diabetes also requires special consideration. As appetite and food intake decrease, insulin requirements may change too. Insulin dosing, hypoglycemia risk, ketones, and automated insulin delivery may need closer monitoring.
Individual response matters.
GLP-1, Perimenopause and Menopause: What Women With Type 1 Diabetes Should Consider
This is the part of the conversation I don't want women to miss.
If you've entered perimenopause or menopause and suddenly notice more insulin resistance, weight gain, changing body composition, poor sleep, or unpredictable blood sugars, don't automatically assume your body has stopped responding to everything you've always done.
Your hormones may be part of the picture.
Changing estrogen and progesterone levels can coincide with changes in sleep, body composition, appetite, and blood sugar management.
A GLP-1 may help address appetite, weight, or metabolic health for an appropriate candidate.
But a GLP-1 doesn't replace estrogen.
That doesn't mean hormone therapy is appropriate for everyone, nor does it mean hormone therapy must come before a GLP-1. It means hormones deserve to be part of the conversation.
Before immediately adding another medication, ask: What changed?
Before Managing Type 1 Diabetes With a GLP-1: Look at the Foundation
This is where I believe we need to set the runway.
Are you getting enough protein? Are you strength training and protecting muscle? How are you sleeping? Are you managing chronic stress? Are you adequately hydrated? Are you eating enough fiber? Have your insulin needs and settings been reassessed?
And have you discussed your perimenopause or menopause symptoms with a healthcare provider who understands hormone health?
Lifestyle doesn't make medication unnecessary for everyone.
In fact, NIDDK emphasizes that weight-management medications work best alongside nutrition, physical activity, and other lifestyle strategies.
Sometimes the answer may ultimately include a GLP-1.
The goal isn't to avoid medication. The goal is to understand why you're using it.
GLP-1 Side Effects: Protecting Muscle and Gut Health
GLP-1 medications can cause gastrointestinal side effects, including nausea, constipation, diarrhea, vomiting, and delayed gastric emptying.
Significant appetite suppression can also make it harder to consume adequate protein and overall nutrition. For women over 40, protecting muscle becomes especially important. Adequate protein and resistance training shouldn't be afterthoughts.
Your gut deserves attention too. If you already struggle with constipation, slowed digestion, or gastroparesis, bring that into the conversation with your healthcare provider.
And know your source.
The FDA warns about safety and quality concerns involving unapproved GLP-1 products. Compounded drugs do not undergo the same FDA premarket review for safety, effectiveness, and quality as FDA-approved medications. The FDA has also reported dosing errors and fraudulent products.
Does Insurance Cover GLP-1 Medications for Type 1 Diabetes?
Insurance can be one of the biggest hurdles.
Because GLP-1 medications aren't FDA-approved specifically for treating type 1 diabetes, coverage may be denied when T1D alone is the reason for the prescription.
Coverage depends on the specific medication, its approved indication, your health history, and your individual insurance plan.
NIDDK notes that some, but not all, insurance plans cover prescription medications for overweight and obesity.
If you and your healthcare provider believe a GLP-1 is medically appropriate, advocate and ask questions.
Ask your insurance company:
What diagnoses and clinical criteria qualify for coverage?
Does this medication require prior authorization?
What documentation does my healthcare provider need to submit?
If I'm denied, what specifically is the reason?
What is the formal appeals process?
Is another medication in the same category covered?
And don't forget one more important question:
Can I sustain the cost long-term if my insurance coverage changes?
Cost and continued access deserve to be part of the decision before starting.
GLP-1 and Menopause: Do You Really Need One?
Maybe.
And I think it's okay for the answer to be not right now, yes, or I need more information first.
I'm not anti-GLP-1. I'm anti-skipping-the-questions.
A GLP-1 can be a powerful tool for the right woman and the right reason. But every increase in weight, appetite, insulin resistance, or blood sugar during menopause doesn't automatically mean another medication is the first answer.
Know your need. Know your body. Know your source.
Then make the decision alongside a healthcare provider who understands type 1 diabetes, GLP-1 medications, and the hormonal changes that can affect women during perimenopause and menopause.
A GLP-1 is a tool. It isn't the foundation.
Want to Learn More About GLP-1s and Type 1 Diabetes?
On Episode 175 of the Type 1 in Midlife Podcast, I sit down with registered dietitian, strength coach, and fellow woman living with type 1 diabetes Kelly Schmidt, RD, LDN.
Kelly has personally used GLP-1 therapy for years, while I currently don't use one. That gave us two different perspectives on the same question.
We talk about GLP-1 medications and type 1 diabetes, insulin sensitivity, gut health, muscle, menopause and hormones, safety, cost, insurance, and how to decide whether a GLP-1 truly belongs in your toolbox.
This article is for educational purposes only and isn't a substitute for individualized medical advice. GLP-1 therapy and changes to insulin or other prescription medications should be discussed with your healthcare provider.
Comments